125 related articles for article (PubMed ID: 24334518)
1. Incidence and risk factors for drug intolerance and association with incomplete treatment for tuberculosis: analysis of national case registers for England, Wales and Northern Ireland, 2001-2010.
Smith C; Abubakar I; Thomas HL; Anderson L; Lipman M; Reacher M
Thorax; 2014 Oct; 69(10):956-8. PubMed ID: 24334518
[TBL] [Abstract][Full Text] [Related]
2. Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
Loutet MG; Davidson JA; Brown T; Dedicoat M; Thomas HL; Lalor MK
Emerg Infect Dis; 2018 Mar; 24(3):524-533. PubMed ID: 29460735
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982-1991.
Warburton AR; Jenkins PA; Waight PA; Watson JM
Commun Dis Rep CDR Rev; 1993 Dec; 3(13):R175-9. PubMed ID: 7507770
[TBL] [Abstract][Full Text] [Related]
4. Increasing antituberculosis drug resistance in the United Kingdom: analysis of National Surveillance Data.
Kruijshaar ME; Watson JM; Drobniewski F; Anderson C; Brown TJ; Magee JG; Smith EG; Story A; Abubakar I
BMJ; 2008 May; 336(7655):1231-4. PubMed ID: 18456593
[TBL] [Abstract][Full Text] [Related]
5. Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance.
Conaty SJ; Hayward AC; Story A; Glynn JR; Drobniewski FA; Watson JM
Epidemiol Infect; 2004 Dec; 132(6):1099-108. PubMed ID: 15635967
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.
Davidson JA; Loutet MG; O'Connor C; Kearns C; Smith RM; Lalor MK; Thomas HL; Abubakar I; Zenner D
Emerg Infect Dis; 2017 Mar; 23(3):377-386. PubMed ID: 28220748
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the completeness of reporting of childhood tuberculosis.
Teo SS; Alfaham M; Evans MR; Watson JM; Riordan A; Sonnenberg P; Clark J; Hayward A; Sharland M; Moore-Gillon J; Novelli V; Quinn D; Shingadia D;
Eur Respir J; 2009 Jul; 34(1):176-9. PubMed ID: 19251788
[TBL] [Abstract][Full Text] [Related]
8. Increase in invasive group A streptococcal infections in England, Wales and Northern Ireland, 2008-9.
Lamagni TL; Efstratiou A; Dennis J; Nair P; Kearney J; George R;
Euro Surveill; 2009 Feb; 14(5):. PubMed ID: 19215717
[TBL] [Abstract][Full Text] [Related]
9. Immigrants and tuberculosis in Hong Kong.
Leung CC; Chan CK; Chang KC; Law WS; Lee SN; Tai LB; Leung EC; Tam CM
Hong Kong Med J; 2015 Aug; 21(4):318-26. PubMed ID: 26183454
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with being lost to follow-up before completing tuberculosis treatment: analysis of surveillance data.
Millett ER; Noel D; Mangtani P; Abubakar I; Kruijshaar ME
Epidemiol Infect; 2013 Jun; 141(6):1223-31. PubMed ID: 22846385
[TBL] [Abstract][Full Text] [Related]
11. First national survey of Mycobacterium tuberculosis drug resistance, Madagascar, 2005-2006.
Ramarokoto H; Ratsirahonana O; Soares JL; Ravaosolo J; Ravololonandriana P; Rakotoarisaonina A; Ranjalahy G; Ranaivohajaina S; Mosa M; Robinson R; Ratsitorahina M; Rasolofo V; Rarivoson B
Int J Tuberc Lung Dis; 2010 Jun; 14(6):745-50. PubMed ID: 20487614
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
Tembo BP; Malangu NG
BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
[TBL] [Abstract][Full Text] [Related]
13. Twenty years and counting: epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and Wales, 1995 to 2014.
Smith CM; Trienekens SC; Anderson C; Lalor MK; Brown T; Story A; Fry H; Hayward AC; Maguire H
Euro Surveill; 2017 Feb; 22(8):. PubMed ID: 28251890
[TBL] [Abstract][Full Text] [Related]
14. National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001.
Shigematsu M; Davison KL; Charlett A; Crowcroft NS
Epidemiol Infect; 2002 Dec; 129(3):459-70. PubMed ID: 12558328
[TBL] [Abstract][Full Text] [Related]
15. Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland.
Gupta RK; Rice B; Brown AE; Thomas HL; Zenner D; Anderson L; Pedrazzoli D; Pozniak A; Abubakar I; Delpech V; Lipman M
Lancet HIV; 2015 Jun; 2(6):e243-51. PubMed ID: 26423197
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.
Aldridge RW; Zenner D; White PJ; Williamson EJ; Muzyamba MC; Dhavan P; Mosca D; Thomas HL; Lalor MK; Abubakar I; Hayward AC
Lancet; 2016 Nov; 388(10059):2510-2518. PubMed ID: 27742165
[TBL] [Abstract][Full Text] [Related]
17. Drug-resistant tuberculosis in Zhejiang Province, China, 1999-2008.
Wang X; Fu Q; Li Z; Chen S; Liu Z; Nelson H; Yang Q; Jia Z; Dye C
Emerg Infect Dis; 2012 Mar; 18(3):496-8. PubMed ID: 22377167
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007.
Anderson LF; Tamne S; Watson JP; Cohen T; Mitnick C; Brown T; Drobniewski F; Abubakar I
Euro Surveill; 2013 Oct; 18(40):. PubMed ID: 24128699
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of multidrug-resistant tuberculosis case notifications in Australia (1999-2018).
Camphor HS; Viney K; Polkinghorne B; Pennington K
Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829704
[TBL] [Abstract][Full Text] [Related]
20. Burden of multidrug-resistant tuberculosis in England: a focus on prevalent cases.
Lalor MK; Perkins S; Thomas HL
Int J Tuberc Lung Dis; 2019 Jun; 23(6):707-713. PubMed ID: 31315703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
